SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Lindholm Jonas)
 

Sökning: WFRF:(Lindholm Jonas) > (2015-2019) > Outcomes associated...

Outcomes associated to serum phosphate levels in patients with suspected acute coronary syndrome

Xu, Hong (författare)
Karolinska Institutet
Evans, Marie (författare)
Karolinska Institutet
Gasparini, Alessandro (författare)
Karolinska Institutet
visa fler...
Szummer, Karolina (författare)
Karolinska Institutet
Spaak, Jonas (författare)
Karolinska Institutet
Ärnlöv, Johan, 1970- (författare)
Karolinska Institutet,Högskolan Dalarna,Medicinsk vetenskap,Uppsala universitet,Institutionen för medicinska vetenskaper
Lindholm, Bengt (författare)
Karolinska Institutet
Jernberg, Tomas (författare)
Karolinska Institutet
Carrero, Juan Jesús (författare)
Karolinska Institutet
visa färre...
 (creator_code:org_t)
Elsevier BV, 2017
2017
Engelska.
Ingår i: International Journal of Cardiology. - : Elsevier BV. - 0167-5273 .- 1874-1754. ; 32
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • BACKGROUND: We investigated the association between phosphate and the risk of adverse clinical outcomes in patients with manifest cardiovascular disease (CVD).METHODS: Observational study of patients hospitalized during 2006-2011 in Stockholm, Sweden, because of suspected acute coronary syndrome (ACS). The exposure was serum phosphate during the hospitalization. We modeled the association between phosphate and in-hospital death or in-hospital events (composite of myocardial infarction, cardiogenic shock, resuscitated cardiac arrest, atrial fibrillation, or atrioventricular block) as well as the one-year post-discharge risk of death or cardiovascular event (composite of myocardial re-infarction, heart failure and stroke). Confounders included demographics, comorbidities, kidney function, diagnoses, in-hospital procedures and therapies.RESULTS: Included were 2547 patients (68% men, mean age 67±14years) with median phosphate of 1.10 (range 0.14-4.20) mmol/L. During hospitalization, 198 patients died and 328 suffered an adverse event. Within one year post-discharge, further 381 deaths and 632 CVD events occurred. The associations of phosphate with mortality and CVD were J-shaped, with highest risk magnitudes at higher phosphate levels. For instance, compared to patients in the 50th percentile of phosphate distribution, those above the 75th percentile (1.3mmol/L, normal range) had significantly higher odds for in-hospital death [odds ratio 1.36, 95% confidence interval (CI) (1.08-1.71)] and of CVD post-discharge [sub-hazard ratios 1.17 (1.03-1.33)].CONCLUSIONS: In patients with suspected ACS, both higher and lower phosphate levels associated with increased risk of adverse outcomes during the index hospitalization and within one year post-discharge. The risk association was present already within normal-range serum phosphate values.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Kardiologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)

Nyckelord

Acute coronary syndrome
Chronic kidney disease
Death
in hospital
Phosphate
Post-discharge
Hälsa och välfärd
Health and Welfare

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy